Company news

ASKA Pharmaceutical Holdings Co., Ltd. news in 2023

ASKA Pharmaceutical Holdings Co., Ltd.'s news releases, calls and decks from 2023, newest first.

View company

ASKA Pharmaceutical Holdings: July 20 2023 ASKA Pharmaceutical Initiates Domestic Phase I II Clinical Trial of Relugolix Combination Tablet (AKP-022)

July 20, 2023

June 27 2023 Personnel Changes of Corporate Officers and Board Members of ASKA Pharmaceutical Holdings Subsidiaries

June 27, 2023

ASKA Pharmaceutical Holdings: June 22 2023 ASKA Pharmaceutical Files an Application for Partial Change of Manufacturing and Marketing Approval for RIFXIMA

June 21, 2023

June 12 2023 NOTICE OF CONVOCATION OF THE 2nd ANNUAL GENERAL MEETING OF SHAREHOLDERS

June 11, 2023

June 12 2023 Matters Subject to Measures for Electronic Provision of the Notice of the 2nd Annual General Meeting of Shareholders

June 11, 2023

June 9 2023 ASKA Pharmaceutical Terminates Joint Research Agreement regarding the Drug Discovery Targeting Specific Ion Channels with RaQualia Pharma

June 9, 2023

ASKA Pharmaceutical Holdings: April 24 2023 ASKA Pharmaceutical Enters into a Comprehensive Business Alliance Agreement on Femtech

April 24, 2023

April 21 2023 ASKA Pharmaceutical Holdings Installs CO₂-Free Electricity and Solar Power Generation Facilities

April 20, 2023

April 7 2023 ASKA Pharmaceutical Terminates Option Agreement with KinoPharma regarding Cervical Dysplasia Treatment

April 6, 2023

March 27 2023 Personnel Change of ASKA Pharmaceutical

March 27, 2023

March 6 2023 Organizational and Personnel Changes of ASKA Pharmaceutical

March 5, 2023

ASKA Pharmaceutical Holdings: February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical® VHH to address an unmet medical need in Obstetrics and Gynecology

February 7, 2023

Decks in 2023